Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Update: Nirsevimab (Beyfortus) – FAQs for Healthcare Professionals
This update from the Pediatric Pandemic Network (PPN) describes the new guidelines from the CDC with additional recommendations from the FDA, AAP, and AAFP. There …
Ask aRCie
Infant Protection Against Respiratory Syncytial Virus (RSV) by Maternal RSV Vaccination or Receipt of Nirsevimab, and Intent for Nirsevimab Receipt, United States [Dataset]
This dataset provides monthly estimates of infant protection against RSV that were calculated using data from the National Immunization Survey–Adult COVID Module (NIS–ACM). The data …
Nirsevimab Coverage, Children 0 to 7 months, United States
The report describes how nirsevimab coverage for infants 0 to 7 months is tracked in the U.S. using data from Immunization Information Systems (IIS). It …
Veterans Health Library: Nirsevimab-alip
This webpage provides drug information for Nirsevimab-alip (Brand Name: Beyfortus®). It addresses why and how it is used, special precautions, dietary instructions, and side effects.
MedlinePlus: Nirsevimab-alip
2024
· American Society of Health-System Pharmacists (ASHP),
· U.S. Department of Health and Human Services (HHS)
This webpage provides drug information on nirsevimab-alip (brand name: Beyfortus®). It addresses why and how it should be used, special precautions, and side effects.
Drug Trials Snapshots: BEYFORTUS
This webpage features a drug trial snapshot for the drug Beyfortus, a monoclonal antibody given as an injection to protect against RSV. Snapshots reveal participants …
ACIP Evidence to Recommendations for Use of Nirsevimab in Children 8–19 Months of Age at Increased Risk of Severe Disease Entering Their Second RSV Season
This webpage provides evidence for the recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the use of nirsevimab for a population of …
Nirsevimab and Abrysvo Update for the 2024-2025 Respiratory Season
2024
· Ohio Department of Health
This webpage provides an update on both infant nirsevimab (Beyfortus®) and maternal RSVpreF (Abrysvo™) administration and planning considerations. Infants can be protected against RSV through …
Making Vaccine Decisions During Pregnancy: What to Know
This newsletter describes the importance of four vaccines during pregnancy: influenza, COVID-19, Tdap, and RSV. These vaccines protect both mothers and babies from severe diseases. …
Respiratory Syncytial Virus (RSV): Advisory Committee on Immunization Practices (ACIP) Recommendations
2024
· Johns Hopkins University
The Advisory Committee on Immunization Practices (ACIP) provides guidelines for preventing Respiratory Syncytial Virus (RSV). Infants up to 8 months should get a dose of …